What is the Choa Pharmaceutical Co., Ltd. stock price forecast?

Choa Pharmaceutical Co., Ltd. is currently trading at ₩920. View real-time AI analysis on Alpha Lenz.

What is Choa Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Choa Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Choa Pharmaceutical Co., Ltd.'s P/E ratio?

Choa Pharmaceutical Co., Ltd.'s P/E ratio is -3.0.

Choa Pharmaceutical Co., Ltd.

KRX · 034940

₩920

Ask about Choa Pharmaceutical Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Choa Pharmaceutical Co., Ltd. trades at a P/E of -3.0 (undervalued) with modest ROE of -26.5%.”

Ask for details →

Company Overview

Choa Pharmaceutical Co., Ltd. is a distinguished entity within the pharmaceutical industry, renowned for its comprehensive approach to the development, manufacturing, and distribution of pharmaceutical products. With a deep commitment to advancing healthcare, Choa Pharmaceutical focuses on creating novel therapies and effective treatments that meet the diverse needs of patients in various therapeutic areas. The company plays a vital role in pharmaceutical innovation, leveraging cutting-edge research and state-of-the-art technology to ensure high-quality product delivery. In the financial market, Choa Pharmaceutical Co., Ltd. stands as a pivotal contributor to the life sciences sector, driving progress and supporting the healthcare ecosystem's growth and sustainability.

CEO조성환, 조성배(각자대표)

Websitehttps://www.choa.co.kr

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Employees268

Company Statistics

FY 2024

Profile

₩28,501,440,840Market Cap

₩62,693,744,120Revenue

30.98MShares Out

268Employees

Margins

33.81%Gross

-9.60%EBITDA

-15.37%Operating

-16.00%Pre-Tax

-16.22%Net

Valuation

-2.97P/E

0.91P/B

0.45EV/Sales

-8.02EV/EBITDA

-5.43P/FCF

Growth (CAGR)

2.89%Rev 3Yr

-1.48%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-13.97%ROA

-26.54%ROE

-12.25%ROIC

Financial Health

₩2,097,261,810Cash & Cash Equivalents

₩40,661,886,620Net Debt

149.71%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Choa Pharmaceutical Co., Ltd. trades at a P/E of -3.0 (undervalued) with modest ROE of -26.5%.”

Ask for details →

Frequently Asked Questions

Choa Pharmaceutical Co., Ltd. (ticker: 034940) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 268 employees. Market cap is $28.5B.

The current price is ₩920 with a P/E ratio of -2.97x and P/B of 0.91x.

ROE is -26.54% and operating margin is -15.37%. Annual revenue is $62.7B.